期刊文献+

硒酵母联合甲巯咪唑治疗Graves病合并甲亢的临床研究 被引量:21

Clinical Study on Effct of Selenium Combining with Methimazole in Graves' Disease Patients with Hyperthyroidism
下载PDF
导出
摘要 目的:观察硒酵母联合甲巯咪唑治疗Graves病合并甲亢的临床疗效及其对甲状腺激素、自身抗体和免疫球蛋白(Ig)水平的影响。方法:选择2011年1月-2012年12月在本院就诊的Graves病合并甲状腺功能亢进的患者80例,随机分为观察组和对照组,每组均为40例;对照组予以甲巯咪唑治疗,观察组在对照组的基础上予以硒酵母治疗。观察两组治疗后的疗效及其对游离三碘甲腺原氨酸(FT3)、游离酶四碘甲腺原氨酸(FT4)、促甲状腺激素激素(TSH)、甲状腺球蛋白抗体(TGAb)、促甲状腺激素受体抗体(TRAb)、甲状腺过氧化物酶抗体(TPOAb)及Ig A、Ig G和Ig M水平的影响。结果:对照组的总有效率为72.50%,观察组的总有效率为92.50%,观察组的总有效率明显优于对照组(χ2=4.242,P<0.05)。治疗后FT3、FT4、TGAb、TPOAb、TRAb、Ig G、Ig A和Ig M水平较治疗前明显降低,TSH较治疗前明显升高,有显著统计学意义(P<0.01),观察组FT3、FT4、TGAb、TPOAb、TRAb、Ig G和Ig A降低水平更为明显,与对照组比较,有明显统计学意义(P<0.01);TSH升高亦有统计学意义(P<0.01);而两组的Ig M水平差异无统计学意义(P>0.05)。结论:硒酵母联合甲巯咪唑治疗Graves病合并甲亢的疗效肯定,具有调节Graves病免疫功能作用。 Objective: To observe the efficacy of selenium combining with methimaole in Graves' disease patients with hyperthyroidism,and its impact on the levels of thyroid hormones,autoantibodies and immunoglobulins( Ig). Methods: 80 Graves' disease patients with hyperthyroidism,were randomly divided into observation group and control group,each group had 40 cases. The control group gaved methimazole,the observation group were given selenium on the basis of the control group. The efficacy after treatment,and its free thyronine( FT3),free four iodine thyronine( FT4),thyroid stimulating hormone( TSH),thyroglobulin antibody( TGAb),thyroid- stimulating hormone receptor antibody( TRAb),thyroid peroxidase antibody( TPOAb),Ig A,Ig G and Ig M were observed before and after treatment in each groups. Results: The total effective rate was92. 50 % in observation group was better than 72. 50% in control group( χ2= 4. 242,P〈0. 05). After treatment,the levels of FT3,FT4,TGAb,TPOAb,TRAb,Ig G,Ig A and Ig M were significantly lower than those before treatment( P〈0. 01),and the levels of FT3,FT4,TGAb,TPOAb,TRAb,Ig G and Ig A in observation group reduced more significant than those in control group( P〈0. 01),TSH level was obviously raised after treatment( P〈0. 01),while the Ig M level showed no significant difference in two groups( P〉0. 05). Conclusion: The efficacy of selenium in Graves' disease patients with hyperthyroidism is obvious,that can regulate the immune function of Graves disease.
作者 龚敏 王爱华
出处 《中国中医药科技》 CAS 2015年第2期130-132,共3页 Chinese Journal of Traditional Medical Science and Technology
基金 上海市浦东新区科技发展基金创新基金(PKJ2013-Y42)
关键词 GRAVES病 甲状腺功能亢进 硒酵母 甲巯咪唑 免疫球蛋白 Graves disease hyperthyroidism selenium methimazole immune globulin
  • 相关文献

参考文献10

  • 1Feroci F, Rettori M, Borrelli A, et al. A systematic review and meta - analysis of total thyroidectomy versus bilateral subtotal thy- roidectomy for Graves" disease [ J ]. Surgery, 2014,155 ( 3 ) : 529 - 540.
  • 2Hautzel H, Pisar E, Yazdan - Doust N, et al. Qualitative and quantitative impact of protective glucocorticoid therapy on the ef- fective 131I half- life in radioiodine therapy for Graves disease[ J] J Nucl Med,2010,51(12) :1917 -1922.
  • 3刘淑(译),施秉银(审校).硒与甲状腺之间的密切联系[J].中华内分泌代谢杂志,2011,27(5):441-443. 被引量:5
  • 4Stefanic M, Kamer I. Thyroid peroxidase autoantibodies are asso- ciated with a lesser likelihood of late reversion to hyperthyroidism after successful nun - ablative treatment of Graves'disease in Croa- tian patients[J]. J Endocrinol Invest,2014,37( 1 ) :71 -77.
  • 5Khong J J, Goldstein R F, Sanders K M, et al. Serum selenium status in Graves'disease with and without orbitopathy: a case - control study [ J ]. Clin Endocrinol (Oxf), 2014,80 ( 6 ): 905 -910.
  • 6Bulow P I, Knudsen N, Carle A, et al. Serum selenium is low in newly diagnosed Graves" disease : a population - based study [ J ]. Clin Endocrinol (Oxf) ,2013,79(4) :584 -590.
  • 7姚龙江,韩玉清,丁福万,张汉东,陆强.血清TRAb水平在Graves病诊治中的重新评价[J].中国免疫学杂志,2013,29(11):1190-1192. 被引量:13
  • 8王俊芳,张薇,李京丽,李昭英.硒对Graves’病患者血清TPOAb、TGAb水平的影响[J].中西医结合心脑血管病杂志,2013,11(4):502-503. 被引量:12
  • 9吴素琴,邹耀武.硒酵母片联合右归丸、左甲状腺素钠治疗原发性甲状腺功能减退症60例疗效观察[J].河北中医,2012,34(8):1177-1180. 被引量:24
  • 10van Zeijl C J, Fliers E, van Koppen C J, et al. Thyrotropin recep- tor- stimulating Graves" disease immunoglobulins induce hyaluro- nan synthesis by differentiated orbital fibroblasts from patients with Graves" ophthalmopathy not only via cyclic adenosine monophos- phate signaling pathways [ J ]. Thyroid,2011,21 (2) : 169 - 176.

二级参考文献31

  • 1刘莉,平智广,朱本章.自身免疫性甲状腺病患者血清硒水平[J].中华内分泌代谢杂志,2005,21(6):537-538. 被引量:24
  • 2Khrle J. Selenium and the control of thyroid hormone metabolism[J].TVroi(i,2005,15(8;) :841 -853.
  • 3林兰.现代中西医内分泌病学[M].北京:中国中医药出版 社,2001:233.
  • 4Mazokopakis EE, Papadakis JA, Papadomanolaki MG, et al. Effects of 12 months treatment with L - selenomethionine on serum anti - TPO levels in Patients withHashimoto sthyroiditis[ J].Thyroid,2007,17(7) :609 - 612.
  • 5Negro R,Greco GyMangieri T,et al. The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies [ J]. J Clin Endocrinol Metab,2007,92(4) :1263 -1268.
  • 6廖二元.八年制内科学FM].第3版.北京:人民卫生出版社,2010:942-953.
  • 7Roberts CG.Ladenson PW. Hypothyroidism[J]. Lancet.2004.363 (9411) : 793 - 803.
  • 8Fung HY. Kologlu M. Collison K. et al . Postpartum thyroid dys-function in Mid Glamorgan[J]. Br MedJ Clin Res Ed. 1988.296 (6617):241-244.
  • 9Mariotti Ss Caturegli P. Piccolo P. et al . Antithyroid peroxidase au-toantibodies in thyroid diseases[J].J Clin Endocrinol Metab.1990. 71(3): 661 - 669.
  • 10KohrleJ.Jakob F. Contempre B. et al . Selenium. the thyroid. and the endocrine system[J]. Endocr Rev.2005.26(7) :944 - 984.

共引文献44

同被引文献153

引证文献21

二级引证文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部